Pacific Biosciences of California, Inc. - Common Stock — Flux de trésorerie (NASDAQ:PACB)

Afficher le graphique complet Full chart

Financials

Flux de trésorerie liés aux activités d'exploitation 19.5 M-111.18 M-263.21 M-259.17 M-206.06 M-111.21 M -111.84 M Flux de trésorerie liés aux activités d'investissement -219.32 M-678.53 M116.08 M4.6 M124 M115.45 M 106.07 M Flux de trésorerie liés aux activités de financement 251.84 M1.17 B9.62 M108.89 M-42.99 M3.43 M 2.91 M Flux de trésorerie disponible 19.5 M-111.18 M-263.21 M-259.17 M-206.06 M-118.92 M -121.21 M

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

PACB

Financials

Pacific Biosciences of California, Inc. - Common Stock

Nouvelles

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

Reasons to Retain TransMedics Stock in Your Portfolio for Now

Pacific Biosciences: Pressure Is Rising (NASDAQ:PACB)

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

Can MDT Stock Gain From Its Planned Acquisition of SPR Therapeutics?

MMED's Latest Study Supports the Strength of 780G SmartGuard Algorithm

QIAGEN Stock Up on the Launch of AI-Powered Workflow Agent Platform

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

PACB & Blank Bio Partner to Advance RNA Foundation Models in Oncology

PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down